United Kingdom

MyoKardia Inc (MYOK.OQ)

MYOK.OQ on NASDAQ Stock Exchange Global Select Market

21 Feb 2018
Change (% chg)

$3.25 (+5.91%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Mark Perry

61 2016 Interim Non-Executive Chairman of the Board, Lead Independent Director

Tassos Gianakakos

44 2013 President, Chief Executive Officer, Director

June Lee

51 2017 Chief Operating Officer

Jake Bauer

38 2016 Senior Vice President - Finance and Corporate Development

Joseph Lambing

54 2014 Senior Vice President - Nonclinical and Pharmaceutical Development